Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Shares Traded Last Trade
  2.50 6.02% 44.00 7,064 11:27:57
Bid Price Offer Price High Price Low Price Open Price
40.00 48.00 44.00 41.50 41.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 4.17 -1.26 -11.40 11
Last Trade Time Trade Type Trade Size Trade Price Currency
11:17:48 O 2,439 40.60 GBX

Fusion Antibodies (FAB) Latest News

More Fusion Antibodies News
Fusion Antibodies Investors    Fusion Antibodies Takeover Rumours

Fusion Antibodies (FAB) Discussions and Chat

Fusion Antibodies Forums and Chat

Date Time Title Posts
07/7/202211:32☆ Fusion Antibodies: from discovery to Clinical supply ☆2,477
28/10/202014:27NEW FAB Fusion Antibodies The Next AVCT53
18/9/202015:23Fusion Antibody II51
17/9/202009:25COVID. RAPID PROGRESS MADE. Ј3M RAISED58
08/2/201221:34Fabio Capello Resigns.......9

Add a New Thread

Fusion Antibodies (FAB) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
10:17:4940.602,439990.23O
07:59:0940.602,000812.00O
07:56:4940.602,6251,065.75O
2022-07-06 16:05:4141.5010,0004,150.00O
2022-07-06 15:25:0241.0510,0004,105.00O
View all Fusion Antibodies trades in real-time

Fusion Antibodies (FAB) Top Chat Posts

DateSubject
07/7/2022
09:20
Fusion Antibodies Daily Update: Fusion Antibodies Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 41.50p.
Fusion Antibodies Plc has a 4 week average price of 39.50p and a 12 week average price of 39.50p.
The 1 year high share price is 142.50p while the 1 year low share price is currently 39.50p.
There are currently 25,963,280 shares in issue and the average daily traded volume is 13,535 shares. The market capitalisation of Fusion Antibodies Plc is £10,774,761.20.
17/6/2022
07:10
whatsthepoint: Have to say I am very surprised that a company growing revenue in the current really troublesome times is not being given a lot more credit. The mark down in share price is truly not a fair reflection of its business performance in my honest opinion. The board need to be a lot more vocal on shouting about how well it is actually doing in such a difficult time.
19/5/2022
08:33
clocktower: Is there any purpose in this company being listed, there are so few shares traded, growth is slow and until such time as they turn a profit, which could be years away if they just keep investing in R&D? Why would they do that you ask, is it not obvious, so many companies that do this to enrich and reward themselves. Did the prospects forecast this spiral of declining share price, are the board of directors rewarded on performance, are their interests aligned with the private investors? How much skin do they have in the entity?
18/5/2022
09:33
clocktower: Dreaming WTP? More likely the share price will fall dramatically and the BoD will issue themselves loads of options at cut price levels, and then the share price will rise along with regular news, until time to cash some out.
06/5/2022
07:44
clocktower: Positive but still loss making but they changes being made to improve commercial opportunities shows there is still a lot of work to be done before this bears any fruit imo. Unless the sales increase a lot further and the losses are reduced it is unlikely the direction of the share price will alter bar receiving a bid. I will continue to hold but not add, as I guess there could be a little increase on this news but I doubt the direction will change over the next six months. DYOR
25/3/2022
16:06
small cap value investor: The point is that you can purchaser 20000 shares at .598 until they are cleared and no new sellers emerge thatis the current position The Commpany needs to make an positive announcement to move the price upwards You would have thought that the Progressive decline in the share price would have encouraged the company to say something Silence in this instance isn't Golden !!
23/3/2022
09:08
small cap value investor: I have been following this thread for some time and at £1.20 I was thinking that this might be an interesting investment however I struggled to find any information released by the company to support a purchase It's seems that a couple of people and one in particular either have an ability to take a much more optimistic view from the information to hand or think that it's possible to talk the share price up. Supply and demand has now taken the share price to £.60 I don't subscribe to the conspiracy theory that the Market Makers are manipulating the share price,they simply want to trade shares at a margin and a comment that it would be good to have a few more purchases before the Weekend wouldn't strike me as a comment from an informed longterm investor Prephaps this is a good entry point but I will wait for news to confirm If I miss the boat so be it but at least I am not holding a load of Shares bought at £1.20 and topped up on the way down I am from Belfast and on a personal note would love to see this company being a success Value Investor
25/2/2022
07:03
whatsthepoint: It's crazy to think the only reason the share price is down here at 65/67 is because the market makers have moved it to this level as a function of dealing with the shareholders selling shares against dealing with anyone buying shares, Yet it is still the same company, that is trading the same making drugs just the same and with exactly the same prospects now as they were when those shares were changing hands at when that was £1 or £1.50 or £2 or £2.50. The price of a company is purely set by the current balance of sellers and buyers. At the current price that the market makers are saying it is at the moment in time. If all of a sudden there was a lot more people wanting to buy the same companies shares today than who want to sell today then the price would dramatically be changed by those same Market makers to a higher price and it could settle at £1.50 or £2 or higher depending on what equilibrium price was needed to reflect the situation where the buyers and sellers was in balance. As time has passed new investors need to study the information or be made aware what the prospects are. This is why it's so important that there is info available from the company to help those buyers and sellers make a judgement of is it good value or bad value at the current price those same market makers are stating on the screens. Now clearly there are other factors that can change that sentiment. But in essence that's how shares are valued. So we all need to accept that. Now as Ryan has said after his discussions and his assessment of the company he believes this price is a major major opportunity to buy rather than sell. But still either the market makers want to keep it lower or there are more sellers selling at this price than buying at That price. So until we get more information to appraise the perceived value to current price the only thing that will change the price is the balance of buyers and sellers. I know it's staying the bleeding obvious but thought it might be good for thought.
10/2/2022
13:24
tracytracy: A picture containing shape Description automatically generated 10 February 2022 Fusion Antibodies plc ("Fusion" or the "Company") Statement re: movement in share price Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, notes the recent movement in the Company’s share price and wish to confirm that the Company is not aware of any specific reason for this. The Board also confirms that the Company remains well capitalised, that current trading for the year ending 31 March 2022 remains in line with expectations and that there have been no material developments since the publication of the Company’s interim results for the six months ended 30 September 2021 on 6 December 2021.
05/2/2022
20:53
cbeadle: Can’t understand why FAB price is declining
26/10/2021
20:46
cumnor: Agree WTP, more likely a forced seller. MMs know there are many gormless PIs invested in microcaps on AIM-some of these companies will eventually hit the big time-who lack the patience, liquidity or understanding of how cbusinesses like FAB evolve. The default position for MMs across the board is to drive the share price as low as possible, even after good news, to flash out naive and financially challenged individuals like today's seller. And they succeed-eventually. These shares will be doshed out to PIs in small lots probably c 140p over next few days. Watch the share price go up on no news over the next week or two, but they may keep it here for a while to gouge a few more mugs who panic. The surprise is they paid 115 for the 50000 shares which, given it can equate to 10 times the volume of most days. In reality I would have expected them to take this volume (not big by any standards) at c £1 but given it was only 5p less than yesterday's offer suggests they are anxious to get their hands on shares, which suggests not too many are flying around.
Fusion Antibodies share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
FAB
Fusion Ant..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220707 10:45:55